sorafenib has been researched along with catechin in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (catechin) | Trials (catechin) | Recent Studies (post-2010) (catechin) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 11,544 | 477 | 6,612 |
| Protein | Taxonomy | sorafenib (IC50) | catechin (IC50) |
|---|---|---|---|
| Arginase | Leishmania amazonensis | 1.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, KH; Chan, KH; Chen, Q; Her, Z; Kurisawa, M; Lai, F; Mong, J; Niibori-Nambu, A; Osato, M; Tan, MH | 1 |
1 other study(ies) available for sorafenib and catechin
| Article | Year |
|---|---|
Bone marrow-targetable Green Tea Catechin-Based Micellar Nanocomplex for synergistic therapy of Acute myeloid leukemia.
Topics: Animals; Bone Marrow; Catechin; Disease Models, Animal; Humans; Leukemia, Myeloid, Acute; Mice; Micelles; Sorafenib; Tea; Tissue Distribution | 2022 |